nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—NR1H4—cardiovascular system—Parkinson's disease	0.0182	0.0706	CbGeAlD
Fulvestrant—ESR2—hindbrain—Parkinson's disease	0.0179	0.0694	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—Parkinson's disease	0.0139	0.0541	CbGeAlD
Fulvestrant—ESR1—hindbrain—Parkinson's disease	0.0122	0.0475	CbGeAlD
Fulvestrant—ESRRA—medulla oblongata—Parkinson's disease	0.0119	0.0462	CbGeAlD
Fulvestrant—ESRRA—midbrain—Parkinson's disease	0.0109	0.0422	CbGeAlD
Fulvestrant—ESRRA—spinal cord—Parkinson's disease	0.0106	0.0412	CbGeAlD
Fulvestrant—ESR2—brainstem—Parkinson's disease	0.0103	0.0398	CbGeAlD
Fulvestrant—ESR2—forebrain—Parkinson's disease	0.00989	0.0384	CbGeAlD
Fulvestrant—EPHX2—cerebellum—Parkinson's disease	0.00961	0.0373	CbGeAlD
Fulvestrant—ESRRA—head—Parkinson's disease	0.00944	0.0366	CbGeAlD
Fulvestrant—ESRRA—nervous system—Parkinson's disease	0.00895	0.0347	CbGeAlD
Fulvestrant—ESRRA—central nervous system—Parkinson's disease	0.00861	0.0334	CbGeAlD
Fulvestrant—ESRRA—cerebellum—Parkinson's disease	0.00842	0.0327	CbGeAlD
Fulvestrant—ESR2—cardiovascular system—Parkinson's disease	0.00836	0.0324	CbGeAlD
Fulvestrant—EPHX2—brain—Parkinson's disease	0.00781	0.0303	CbGeAlD
Fulvestrant—ESR1—embryo—Parkinson's disease	0.00766	0.0297	CbGeAlD
Fulvestrant—ESR1—brainstem—Parkinson's disease	0.00702	0.0272	CbGeAlD
Fulvestrant—ESRRA—brain—Parkinson's disease	0.00684	0.0265	CbGeAlD
Fulvestrant—ESR1—forebrain—Parkinson's disease	0.00678	0.0263	CbGeAlD
Fulvestrant—ESR1—cardiovascular system—Parkinson's disease	0.00573	0.0222	CbGeAlD
Fulvestrant—ESR2—head—Parkinson's disease	0.00566	0.022	CbGeAlD
Fulvestrant—ESR2—nervous system—Parkinson's disease	0.00537	0.0208	CbGeAlD
Fulvestrant—ESR2—central nervous system—Parkinson's disease	0.00517	0.0201	CbGeAlD
Fulvestrant—ESR2—cerebellum—Parkinson's disease	0.00505	0.0196	CbGeAlD
Fulvestrant—ESR2—brain—Parkinson's disease	0.0041	0.0159	CbGeAlD
Fulvestrant—ESR1—head—Parkinson's disease	0.00388	0.015	CbGeAlD
Fulvestrant—ESR1—nervous system—Parkinson's disease	0.00368	0.0143	CbGeAlD
Fulvestrant—ESR1—central nervous system—Parkinson's disease	0.00354	0.0137	CbGeAlD
Fulvestrant—ESR1—cerebellum—Parkinson's disease	0.00346	0.0134	CbGeAlD
Fulvestrant—ESR1—brain—Parkinson's disease	0.00281	0.0109	CbGeAlD
Fulvestrant—CYP3A4—nervous system—Parkinson's disease	0.00205	0.00796	CbGeAlD
Fulvestrant—CYP3A4—central nervous system—Parkinson's disease	0.00198	0.00766	CbGeAlD
Fulvestrant—ESRRA—Metabolism—NDUFB11—Parkinson's disease	0.00177	0.00238	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—FGF20—Parkinson's disease	0.00176	0.00237	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00175	0.00236	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PRKRA—Parkinson's disease	0.00174	0.00235	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00174	0.00234	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00171	0.00231	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.0017	0.00229	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GCH1—Parkinson's disease	0.00169	0.00227	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00169	0.00227	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00163	0.0022	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—RPL6—Parkinson's disease	0.00154	0.00208	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00154	0.00207	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00152	0.00205	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00152	0.00205	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GBA—Parkinson's disease	0.0015	0.00202	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—FBP1—Parkinson's disease	0.0015	0.00202	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—DBH—Parkinson's disease	0.0015	0.00202	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—INS—Parkinson's disease	0.00148	0.002	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00146	0.00197	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00145	0.00196	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ND3—Parkinson's disease	0.00145	0.00195	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MCCC1—Parkinson's disease	0.00145	0.00195	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR4A2—Parkinson's disease	0.00141	0.0019	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—TAF1—Parkinson's disease	0.00141	0.0019	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00141	0.0019	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—DDC—Parkinson's disease	0.00138	0.00186	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TALDO1—Parkinson's disease	0.00136	0.00183	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—OMD—Parkinson's disease	0.00136	0.00183	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00135	0.00181	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00132	0.00178	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTA4—Parkinson's disease	0.0013	0.00175	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NDUFB11—Parkinson's disease	0.00129	0.00174	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00129	0.00173	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00129	0.00173	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GCH1—Parkinson's disease	0.00123	0.00166	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—TAF1—Parkinson's disease	0.00123	0.00166	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR4A2—Parkinson's disease	0.00123	0.00166	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PLA2G6—Parkinson's disease	0.00117	0.00158	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—RPL23A—Parkinson's disease	0.00117	0.00158	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—RPL14—Parkinson's disease	0.00117	0.00158	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MAOB—Parkinson's disease	0.00116	0.00156	CbGpPWpGaD
Fulvestrant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00116	0.00156	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00115	0.00155	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—RPL6—Parkinson's disease	0.00113	0.00152	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00111	0.0015	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00111	0.00149	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.0011	0.00149	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—DDC—Parkinson's disease	0.0011	0.00149	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.0011	0.00148	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GBA—Parkinson's disease	0.0011	0.00148	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—DBH—Parkinson's disease	0.0011	0.00148	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—FBP1—Parkinson's disease	0.0011	0.00148	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—RPS8—Parkinson's disease	0.00109	0.00147	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00107	0.00144	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00106	0.00143	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTA4—Parkinson's disease	0.00104	0.0014	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00103	0.00139	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—MAPK8—Parkinson's disease	0.00102	0.00137	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00101	0.00136	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00101	0.00136	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPL6—Parkinson's disease	0.000983	0.00132	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000981	0.00132	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00098	0.00132	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000967	0.0013	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000959	0.00129	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PLA2G6—Parkinson's disease	0.000937	0.00126	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MAOB—Parkinson's disease	0.000928	0.00125	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000921	0.00124	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—IL1B—Parkinson's disease	0.000914	0.00123	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000896	0.00121	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000884	0.00119	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000883	0.00119	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PRKRA—Parkinson's disease	0.00088	0.00119	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000877	0.00118	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—HSPA8—Parkinson's disease	0.000875	0.00118	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—CTGF—Parkinson's disease	0.000871	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000864	0.00116	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP2D6—Parkinson's disease	0.000863	0.00116	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000856	0.00115	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—RPL23A—Parkinson's disease	0.000855	0.00115	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—RPL14—Parkinson's disease	0.000855	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00085	0.00114	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CTGF—Parkinson's disease	0.000847	0.00114	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—MAPK8—Parkinson's disease	0.000838	0.00113	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—DDC—Parkinson's disease	0.000806	0.00109	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.0008	0.00108	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—RPS8—Parkinson's disease	0.000798	0.00107	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—HSPA1A—Parkinson's disease	0.000796	0.00107	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000794	0.00107	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP2E1—Parkinson's disease	0.000789	0.00106	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000787	0.00106	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NQO1—Parkinson's disease	0.00078	0.00105	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—TH—Parkinson's disease	0.000769	0.00104	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000768	0.00104	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000767	0.00103	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTA4—Parkinson's disease	0.000761	0.00103	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000751	0.00101	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPL23A—Parkinson's disease	0.000745	0.001	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPL14—Parkinson's disease	0.000745	0.001	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYCS—Parkinson's disease	0.000738	0.000995	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000732	0.000986	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000726	0.000979	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPS8—Parkinson's disease	0.000695	0.000936	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP2D6—Parkinson's disease	0.00069	0.000929	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PLA2G6—Parkinson's disease	0.000685	0.000923	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MAOB—Parkinson's disease	0.000678	0.000914	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CTGF—Parkinson's disease	0.000677	0.000912	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—COMT—Parkinson's disease	0.000654	0.000881	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTP1—Parkinson's disease	0.000651	0.000877	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MAOA—Parkinson's disease	0.000649	0.000875	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—Parkinson's disease	0.000648	0.000874	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000645	0.00087	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—HMOX1—Parkinson's disease	0.000642	0.000865	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HSPA8—Parkinson's disease	0.000639	0.000861	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000637	0.000858	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—CTGF—Parkinson's disease	0.000636	0.000857	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP2E1—Parkinson's disease	0.000631	0.00085	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000628	0.000846	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NQO1—Parkinson's disease	0.000624	0.00084	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000623	0.000839	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TAF1—Parkinson's disease	0.00062	0.000835	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR4A2—Parkinson's disease	0.00062	0.000835	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ABCB1—Parkinson's disease	0.000616	0.00083	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—TH—Parkinson's disease	0.000615	0.000828	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTM1—Parkinson's disease	0.000598	0.000806	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000598	0.000805	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000591	0.000796	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYCS—Parkinson's disease	0.00059	0.000795	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HSPA1A—Parkinson's disease	0.000582	0.000784	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00058	0.000782	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GPX1—Parkinson's disease	0.000573	0.000772	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VPS35—Parkinson's disease	0.000572	0.000771	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000568	0.000765	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000566	0.000762	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA8—Parkinson's disease	0.000557	0.00075	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—CTGF—Parkinson's disease	0.000554	0.000747	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MTHFR—Parkinson's disease	0.000528	0.000712	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—COMT—Parkinson's disease	0.000523	0.000704	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000521	0.000702	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTP1—Parkinson's disease	0.00052	0.000701	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MAOA—Parkinson's disease	0.000519	0.000699	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HMOX1—Parkinson's disease	0.000513	0.000691	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA1A—Parkinson's disease	0.000507	0.000683	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2D6—Parkinson's disease	0.000504	0.000679	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL6—Parkinson's disease	0.000496	0.000668	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CTGF—Parkinson's disease	0.000495	0.000667	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ABCB1—Parkinson's disease	0.000492	0.000664	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOE—Parkinson's disease	0.000492	0.000663	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTM1—Parkinson's disease	0.000478	0.000644	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GPR37—Parkinson's disease	0.000474	0.000639	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DGKQ—Parkinson's disease	0.000474	0.000639	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2E1—Parkinson's disease	0.000461	0.000621	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GPX1—Parkinson's disease	0.000458	0.000617	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NQO1—Parkinson's disease	0.000456	0.000614	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TH—Parkinson's disease	0.000449	0.000605	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000434	0.000584	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000432	0.000582	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYCS—Parkinson's disease	0.000431	0.000581	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MTHFR—Parkinson's disease	0.000422	0.000569	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000422	0.000568	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—INS—Parkinson's disease	0.00042	0.000566	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000416	0.000561	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000397	0.000535	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOE—Parkinson's disease	0.000393	0.00053	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000386	0.00052	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—COMT—Parkinson's disease	0.000382	0.000515	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000381	0.000513	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—Parkinson's disease	0.00038	0.000512	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MAOA—Parkinson's disease	0.000379	0.000511	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000379	0.000511	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000376	0.000506	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000376	0.000506	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—Parkinson's disease	0.000375	0.000505	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCB1—Parkinson's disease	0.00036	0.000485	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.000359	0.000484	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPS8—Parkinson's disease	0.00035	0.000472	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—Parkinson's disease	0.000349	0.000471	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—INS—Parkinson's disease	0.000336	0.000453	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GPX1—Parkinson's disease	0.000335	0.000451	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM4—Parkinson's disease	0.000322	0.000434	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.00032	0.000431	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000318	0.000429	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000317	0.000428	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000315	0.000425	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000314	0.000423	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000314	0.000423	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTHFR—Parkinson's disease	0.000309	0.000416	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PENK—Parkinson's disease	0.000305	0.000412	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAG—Parkinson's disease	0.000305	0.000412	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	0.000304	0.00041	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000292	0.000394	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000288	0.000389	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—Parkinson's disease	0.000287	0.000387	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA8—Parkinson's disease	0.000281	0.000378	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CTGF—Parkinson's disease	0.000279	0.000376	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDYN—Parkinson's disease	0.000279	0.000376	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GFAP—Parkinson's disease	0.000263	0.000354	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM5—Parkinson's disease	0.00026	0.00035	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA1A—Parkinson's disease	0.000256	0.000344	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INS—Parkinson's disease	0.000246	0.000331	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF20—Parkinson's disease	0.000228	0.000307	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000221	0.000298	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000207	0.000279	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000207	0.000279	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INSR—Parkinson's disease	0.000204	0.000275	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000195	0.000263	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000195	0.000263	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGB—Parkinson's disease	0.000193	0.00026	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000192	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TAC1—Parkinson's disease	0.000189	0.000254	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DRD1—Parkinson's disease	0.000185	0.000249	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000185	0.000249	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DRD3—Parkinson's disease	0.000179	0.000241	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000176	0.000238	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000167	0.000226	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR7—Parkinson's disease	0.000162	0.000218	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DRD2—Parkinson's disease	0.000162	0.000218	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000157	0.000212	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000157	0.000212	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000157	0.000212	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—Parkinson's disease	0.000136	0.000183	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000131	0.000177	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDN1—Parkinson's disease	0.00013	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NGF—Parkinson's disease	0.000119	0.000161	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000115	0.000155	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000114	0.000153	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000109	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—Parkinson's disease	0.000106	0.000142	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.81e-05	0.000132	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MAOB—Parkinson's disease	9.71e-05	0.000131	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INS—Parkinson's disease	9.02e-05	0.000121	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	7.21e-05	9.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CTGF—Parkinson's disease	7.08e-05	9.54e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—Parkinson's disease	6.71e-05	9.04e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.6e-05	8.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.52e-05	8.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TH—Parkinson's disease	6.43e-05	8.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYCS—Parkinson's disease	6.17e-05	8.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	6.17e-05	8.31e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COMT—Parkinson's disease	5.47e-05	7.37e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.44e-05	7.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MAOA—Parkinson's disease	5.43e-05	7.31e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—Parkinson's disease	5.37e-05	7.23e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.15e-05	6.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5e-05	6.74e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.79e-05	6.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.42e-05	5.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—Parkinson's disease	4.11e-05	5.54e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—Parkinson's disease	3.94e-05	5.31e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INS—Parkinson's disease	3.51e-05	4.74e-05	CbGpPWpGaD
